Also, inhibition of mTOR using T cell-specific aptamers delivering mTORC1 specific siRNA or by Temsirolimus resulted in an enhanced anti-tumor effector response and vaccine-derived immunity [18, 29]. The gene discussed is MTOR; the disease is neoplasm.